1. Home
  2. Medical Research
  3. Boston, MA
  4. For Henry Ahc

For Henry Ahc

  • Boston, MA
  • Tax-exempt since 2024
  • EIN: 92-1330008
forhenryahc.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate

Organization summary

For Henry Ahc is a 501(c)(3) organization, classified under Medical Research (NTEE H20). Contributions are tax-deductible.

Po Box 170129, Boston, MA 02117-0089

In fiscal year 2025 it reported $646,193 in revenue and $1,132,948 in expenses, with contributions making up 95.3% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

For Henry Ahc's mission is to fund research to develop a treatment for ahc. Our current main focus is funding research to develop an aso (antisnese oligonucleotide) treatment for a specific genetic mutation that causes ahc, which will forge a path for other aso's to be developed for other patients with ahc caused by other genetic mutations, as well as other similar genetic neurological diseases.

Largest programs · fiscal year 2025

  • Aso program: This program encompasses all preclinical work necessary to fund and devleop a human aso treatment. So far, this project has entailed wgs at illumina, aso sequence development at charles river laboratories, and the aso design and screening as well as functional electrophysiological studies led by dr. Tim yu's lab at Boston children's hospital in collaboration with dr. George's lab at n… Read more

    Aso program: This program encompasses all preclinical work necessary to fund and devleop a human aso treatment. So far, this project has entailed wgs at illumina, aso sequence development at charles river laboratories, and the aso design and screening as well as functional electrophysiological studies led by dr. Tim yu's lab at Boston children's hospital in collaboration with dr. George's lab at northwestern. Included in this project are mouse tolerability and proof of concept studies at the rare disease translational center at the jackson laboratories. Mouse aso proof of concept studies: This project entails support for 3 mouse aso proof of concept studies at the rare disease translation center at the jackson laboratories which will benefit the entire ahc community by illustrating the best and worst case scenario for mouse phenotypic rescue with an aso design for mice, targeting 2 ahc causing mutations.

    $1,132,948 spent · 100.0% of program spending
  • Drug repurposing studies: We have also funded work for a drug repurposing screen through a company called rareshift which has served as a pilot for our ahc community, in collaboration with two other projects funded by other ahc organizations. This project helps us better understand common pathways for medications that may be used to treat ahc, potentially across multiple mutations. The data result… Read more

    Drug repurposing studies: We have also funded work for a drug repurposing screen through a company called rareshift which has served as a pilot for our ahc community, in collaboration with two other projects funded by other ahc organizations. This project helps us better understand common pathways for medications that may be used to treat ahc, potentially across multiple mutations. The data resulted from this screen will inform future drug repurposing studies in mice as well.

Where each dollar went · fiscal year 2025

Of every dollar it spent, 100¢ went to programs, 0¢ to management and 0¢ to fundraising.

  • Programs $1,132,948
  • Management $0
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$646,193Fiscal year 20252025: $646,1932025
Expenses$1,132,948Fiscal year 20252025: $1,132,9482025
Total assets$650,307Fiscal year 20252025: $650,3072025
Total liabilities$0Fiscal year 20252025: $02025
Fiscal year ending December 2025
Revenue$646,193
Expenses$1,132,948
Net income−$486,755
Net assets$650,307

Notable sources of revenue

Percent of total revenue
Contributions$615,984
Program services$0
Investment income$30,209
Other (net)$0

Assets / debt

Total assets$650,307
Total liabilities$0
Net assets$650,307

Compensation

Not in our extract for this year.

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?